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Summary
Vasopressin modulates many social and nonsocial be-
haviors, including emotionality. We have previously re-
ported that male mice with a null mutation in the V1a
receptor (V1aR) exhibit a profound impairment in so-
cial recognition and changes in anxiety-like behavior.
Using site-specific injections of a V1aR-specific an-
tagonist, we demonstrate that the lateral septum, but
not the medial amygdala, is critical for social recogni-
tion. Reexpressing V1aR in the lateral septum of V1aR
knockout mice (V1aRKO) using a viral vector resulted
in a complete rescue of social recognition. Further-
more, overexpression of the V1aR in the lateral sep-
tum of wild-type (wt) mice resulted in a potentiation
of social recognition behavior and a mild increase in
anxiety-related behavior. These results demonstrate
that the V1aR in the lateral septum plays a critical role
in the neural processing of social stimuli required for
complex social behavior.
Introduction
Vasopressin (AVP) is a peptide produced in the hypo-
thalamus and is both a neurohypophysial peptide re-
leased into circulation by the posterior pituitary, where
it affects renal and vascular function, and a neuromodula-
tor produced and released in specific regions throughout
the brain, where it affects a wide range of behaviors
(Landgraf et al., 1998). AVP was one of the first peptides
to be characterized, and its peripheral roles in fluid
homeostasis and blood pressure control have been
extensively investigated. The specific behavioral roles
for central AVP, the first of which was originally de-
scribed in the 1960s by David de Wied, are still murky
and under active investigation (reviewed in van Wimer-
sma Greidanus et al., 1983; Engelmann et al., 1996).
AVP has been associated with a wide number of behav-
iors including flank-marking behavior, paternal behav-
ior, social recognition, aggression, affiliation behavior,
and anxiety-like behavior (Ferris et al., 1984, 1986; Le*Correspondence: alanwithisa@yahoo.comMoal et al., 1987; Winslow et al., 1993; Landgraf et al.,
1995; Bamshad and Albers, 1996; Liebsch et al., 1996;
Everts and Koolhaas, 1997; Young et al., 1999; Parker
et al., 2001; Pitkow et al., 2001). The existence of three
major receptor types for AVP and the extensive distri-
bution of AVP throughout the brain present a challenge
for determining the neuroanatomical and neurochemi-
cal specifics of AVP in particular behaviors.
While AVP binds to three major receptors, only two
exist in the central nervous system, the V1a and V1b
receptor subtypes. The V1aR is located in many regions
throughout the brain, while the V1bR is located primar-
ily in the pituitary and in several other discrete areas of
the brain including the amygdala (Johnson et al., 1993;
de Vries and Miller, 1998; Hernando et al., 2001). Phar-
macological manipulations using intracerebroventricu-
lar (icv) and intraseptal injections of V1aR-specific
antagonists have been shown to affect both social be-
haviors and anxiety-like behaviors in rats (Dantzer et
al., 1987; Engelmann and Landgraf, 1994; Everts and
Koolhaas, 1999). Furthermore, administration of V1aR
antisense oligos into the septal region resulted in im-
paired social recognition and altered anxiety-like be-
haviors (Landgraf et al., 1995).
While most of the evidence for AVP’s effects on be-
havior has focused on the V1aR, there is mounting evi-
dence that the V1bR may also play a role in these be-
haviors. Anxiety-like behavior was found to be altered
after treatment with an orally active V1bR antagonist;
however, characterization of a V1bR knockout mouse
found no difference in anxiety-like behavior, but a sig-
nificant effect on aggression and a mild impairment of
social behavior (Griebel et al., 2002; Wersinger et al.,
2002). It is possible that the different AVP receptors fa-
cilitate distinct behaviors.
We have previously reported that mice with a null mu-
tation in the V1aR display a profound impairment in so-
cial recognition and a marked reduction in anxiety-like
behaviors (Bielsky et al., 2004). Site-specific treatment
with a V1aR viral vector into the lateral septum of normal
rats resulted in an increase in V1aR binding of around
300% and a significant potentiation of social discrimi-
nation. Subsequent administration of a V1aR antago-
nist abolished this effect (Landgraf et al., 2003). Oxyto-
cin, a closely related neuropeptide, has also been
shown to be important in the regulation of social re-
cognition in mice, particularly in the medial amygdala
(Ferguson et al., 2000, 2001). Given the pharmacologi-
cal and behavioral findings from all of these studies, the
V1aR appears to be an important target for the study of
AVP and social behaviors. Furthermore, the site-spe-
cific social effects of V1aR and oxytocin manipulations
in the lateral septum and medial amygdala make these
areas of particular interest in the study of social rec-
ognition. It is possible that V1aR-specific activation in
either the lateral septum or the medial amygdala is critical
for normal social recognition.
We attempt to address these possibilities by testing
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504FFigure 1. Social Recognition and Lateral Septum V1aR Antagonist
nInjections
SSocial recognition effects of lateral septum V1aR antagonist treat-
tment (open circles; n = 9) and vehicle treatment (closed circles; n =
n8) in wt mice was measured as a difference in olfactory investiga-
gtion of the same ovariectomized female during each of four succes-
csive 1 min trials (ITI = 10 min). A fifth dishabituation trial depicts the
tresponse to a novel female in a 1 min pairing 10 min after the fourth
ftrial. Wt mice treated with lateral septum vehicle injections showed
Va significant decrease in olfactory investigation after repeated pair-
tings of the same female on trials 2, 3, and 4. Wt mice treated with
tlateral septum V1aR antagonist injections never showed a de-
rcrease in olfactory investigation. *p < 0.001. Error bars represent
t±SEM. Asterisks represent a significant decrease between each
trial as compared to the first trial.rthe effects of site-specific V1aR antagonists on the so-
2cial recognition behaviors of wild-type (wt) male mice
0and the effects of viral vector V1aR expression in both
gV1aRKO and wt mice. We chose both the lateral sep-
ftum and the medial amygdala as site-specific targets
Pfor the V1aR antagonists and then assessed the effects
jof these bilateral injections on social recognition in or-
sder to determine the importance of both the specific
ureceptor subtype and the neuroanatomical specificity
tof receptor activation on normal social recognition be-
chavior.
nWe then used the results from these antagonist
nstudies to determine which regions should be targeted
iwith the V1aR viral vector in both V1aRKO and wt mice.
iThe V1aRKO mice treated with the V1aR viral vector
shad renewed V1aR binding in only those areas tar-
dgeted, while the wt mice had increased V1aR bindings
tin the specific areas targeted. Social recognition and
aanxiety-related behavior was then assessed in these
fgroups in order to determine the neuroanatomical
Vspecificity and behavioral dependence on V1aR bind-
Wing in discrete brain regions. These studies demon-
wstrate that viral vector gene transfer used in conjunc-
ction with transgenic mouse technology provides a
evaluable method for the study of the role of localized





uV1a Receptor Antagonist in Lateral Septum
tWt mice bilaterally injected with V1aR antagonist intothe lateral septum showed a significant deficit in socialigure 2. Social Recognition and Medial Amygdala V1aR Antago-
ist Injections
ocial recognition effects of medial amygdala V1aR antagonist
reatment (open circles; n = 9) and vehicle treatment (closed circles;
= 8) in wt mice was measured as a difference in olfactory investi-
ation of the same ovariectomized female during each of four suc-
essive 1 min trials (ITI = 10 min). A fifth dishabituation trial depicts
he response to a novel female in a 1 min pairing 10 min after the
ourth trial. Wt mice treated with both medial amygdala vehicle and
1aR antagonist injections showed a significant decrease in olfac-
ory investigation after repeated pairings of the same female on
rials 2, 3, and 4. *p < 0.001. Error bars represent ±SEM. Asterisks
epresent a significant decrease between each trial as compared
o the first trial.ecognition. Significant main effects for trial [F(4, 15) =
6.276; p < 0.001] and treatment [F(1, 15) = 38.170; p <
.001] were detected for time spent in olfactory investi-
ation of a stimulus female. A significant interaction ef-
ect was also detected [F(4, 15) = 14.702; p < 0.001].
ost hoc analysis revealed that wt mice bilaterally in-
ected with vehicle into the lateral septum showed a
ignificant decrease in social olfactory investigation
pon subsequent presentations of the same female in
rials 2 (p < 0.001), 3 (p < 0.001), and 4 (p < 0.001) as
ompared to trial 1. The mice treated with the antago-
ist had significantly impaired social recognition and
ever demonstrated a significant reduction in olfactory
nvestigation in any of the trials (Figure 1). The olfactory
nvestigation decrease seen in the vehicle-treated wt
ubjects in trials 2, 3, and 4 was not due to a general
ecrease in olfactory investigation, because presenta-
ion of a novel female during trial 5 resulted in a similar
mount of investigation as trial 1 with the original
emale.
1a Receptor Antagonist in Medial Amygdala
t mice bilaterally injected into the medial amygdala
ith either V1aR antagonist or vehicle showed no defi-
its in social recognition. There was no significant main
ffect for treatment [F(1, 13) = 1.357; p = 0.265] and no
ignificant interaction effect [F(4, 13) = 1.436; p =
.235]. There was a significant main effect for trial [F(4,
3) = 75.960; p < 0.001]. Post hoc analysis revealed
hat both medial amygdala treatment groups showed a
ignificant decrease in social olfactory investigation
pon subsequent presentations of the same female in
rials 2 (p < 0.001), 3 (p < 0.001), and 4 (p < 0.001) ascompared to trial 1. The wt mice in both groups showed
V1aR and Social Cognition
505a typical dishabituation to a novel female as measured
by an increase in olfactory investigation in trial 5 as
compared to trials 2 (p < 0.05), 3 (p < 0.001), and 4 (p <
0.001) (Figure 2). Therefore, it is clear that the olfactory
investigation decrease seen in both medial amygdala
treatment groups in trials 2, 3, and 4 was not due to a
general decrease in olfactory investigation.
Reexpression of V1aR in V1aRKO
Anxiety-Related Behaviors
There was no difference between the V1aRKO mice
treated with the NSE-V1aR and LacZ viral vectors in
the lateral septum on any of the tests for anxiety-like
behavior. NSE-V1aR- and LacZ-treated V1aRKOs spent
similar time in the open arm in the elevated plus maze
(p = 0.314), in the open area of the open field test (p =
0.208), and in the light box in the light/dark box test
(p = 0.272) (Figure 3). There was also no significant
treatment effect in overall locomotor activity in the ele-
vated plus maze as measured by the number of dark
arm entries (p = 0.651) and the distance traveled in the
open field test (p = 0.06).
Social Recognition and Olfactory Habituation
V1aR reexpression using the NSE-V1aR viral vector in
the lateral septum resulted in a complete rescue of so-
cial recognition in the V1aRKO males. The V1aRKO
males that were treated with the control LacZ virus
showed the significant deficit in social recognition pre-
viously reported for untreated V1aRKO mice (Bielsky et
al., 2004). Significant main effects for treatment [F(1,
21) = 25.053; p < 0.001] and trial [F(4, 21) = 26.611; p <
0.001] were detected for time spent in olfactory investi-
gation of a stimulus female. A significant interaction ef-
fect was also detected [F(4, 21) = 15.141; p < 0.001].
Post hoc analysis revealed that NSE-V1aR viral vector-
treated mice showed a significant decrease in olfactoryFigure 3. Anxiety-Related Behaviors in V1aRKO
Anxiety-related behaviors for LacZ virus-treated (filled bars; n = 8)
and NSE-V1aR viral vector-treated (open bars; n = 15) V1aRKO
male mice. There was no difference between the LacZ- and NSE-
V1aR-treated mice on any of the anxiety-related behavior tests, as
they spent similar time in the open arm of the plus maze test, the
open area of the open field test, and the light box in the light/dark
box test. Error bars represent SEM.investigation upon subsequent presentations of thesame female in trials 2 (p < 0.001), 3 (p < 0.001), and
4(p < 0.001) as compared to trial 1.V1aRKO treated with
the control LacZ virus had significantly impaired social
recognition and never demonstrated a reduction in ol-
factory investigation in any of the trials (Figure 4A). The
olfactory investigation decrease seen in the NSE-V1aR-
treated subjects in trials 2, 3, and 4 was not due to
a general decrease in olfactory investigation, because
presentation of a novel female during trial 5 resulted
in a similar amount of investigation as trial 1 with the
original female.
The lack of social recognition in the LacZ-treated
V1aRKO was not due to a general deficit in olfaction,
as both the NSE-V1aR and LacZ virus-treated V1aRKOFigure 4. Social Recognition and Olfactory Habituation
(A) Social recognition in NSE-V1aR viral vector-treated (open cir-
cles; n = 15) and LacZ virus-treated (closed circles; n = 8) V1aRKO
mice was measured as a difference in olfactory investigation of the
same ovariectomized female during each of four successive 1 min
trials (ITI = 10 min). A fifth dishabituation trial depicts the response
to a novel female in a 1 min pairing 10 min after the fourth trial.
NSE-V1aR viral vector-treated V1aRKO mice showed a significant
decrease in olfactory investigation after repeated pairings of the
same female on trials 2, 3, and 4. LacZ virus-treated V1aRKO mice
never showed a decrease in olfactory investigation. (B) Olfactory
habituation was measured as a difference in olfactory investigation
of an anise-scented cotton ball during each of four successive 1
min trials (ITI = 10 min). The fifth, dishabituation trial depicts the
response to a coconut-scented cotton ball in a 1 min exposure 10
min after the fourth trial. Both LacZ-treated (n = 8) and NSE-V1aR-
treated (n = 15) mice showed a decrease in investigation upon sub-
sequent presentations of the same-scented cotton ball on trials 2,
3, and 4. *p < 0.001. Error bars represent ±SEM. Asterisks represent
a significant decrease between each trial as compared to the first
trial.subjects habituated to repeated presentations of a same-
Neuron
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sscented cotton ball. A significant effect for trial [F(4,
l21) = 130.905; p < 0.001] but not treatment [F(1, 21) =
e3.653; NS] was detected for the time spent in olfactory
winvestigation. Post hoc analysis revealed that both NSE-
aV1aR- and LacZ-treated V1aRKO mice showed a signifi-
scant decrease in the time spent in olfactory investiga-
ition of a same-scented cotton ball on trials 2, 3, and 4
s(p < 0.001) (Figure 4B). Again, this was not due to a
general decrease in olfactory investigation, because
presentation of a novel-scented cotton ball on trial 5 D
resulted in a similar amount investigation as trial 1 with
the original scent. There was no treatment difference in T
the amount of initial investigation in either test. t
Receptor Autoradiography i
There was no effect on V1aR binding of the LacZ virus w
treatment in the V1aRKO. The LacZ-treated V1aRKO h
had a complete lack of V1aR binding throughout the f
brain including the lateral septum (Figure 7C). The NSE- a
V1aR viral vector treatment into the lateral septum re- r
sulted in very high levels of V1aR binding in the lateral m
septum; however, there was some spread into the sur- a
rounding regions including the medial septum (Figure f
7D). All other regions lacked V1aR binding. s
i
i
Overexpression of V1aR in Wt Mice V
Anxiety-Related Behavior o
Overexpression of the V1aR in the lateral septum of wt
mice resulted in an increase in anxiety-related behavior p
as measured by the light/dark box test. NSE-V1aR viral s
vector-treated wt mice spent significantly less time in c
the light part of the light/dark box as compared to the (
control LacZ virus-treated wt mice (p < 0.05) (Figure m
5A). There was no significant treatment effect in overall m
locomotor activity as measured by the number of light s

















Figure 5. Anxiety-Related Behaviors in Wt i
Anxiety-related behaviors for LacZ virus-treated (filled bars; n = 10) N
and NSE-V1aR viral vector-treated (open bars; n = 12) wt male o
mice. Lateral septum NSE-V1aR viral vector-treated wt mice spent Rsignificantly less time in the light box of the light/dark box as com-
Vpared to the lateral septum control LacZ virus-treated wt mice (A).
wThere was no difference between the NSE-V1aR- and LacZ-treated
wt mice in the number of light box entries (B). Error bars represent m
SEM. *p < 0.05. e
tocial Discrimination
1aR overexpression using the NSE-V1aR viral vector
n wt mice resulted in a significant improvement in so-
ial discrimination as compared to control LacZ virus-
reated wt. After IEI of 0.5 hr (p < 0.001), 2 hr (p < 0.001),
hr (p < 0.001), and up to 24 hr (p < 0.01) (Figures 6A–
D, respectively) the NSE-V1aR-treated wt mice were
ble to recognize a previously encountered female, as
hey spent significantly less time investigating the same
emale and significantly more time investigating the
ovel female. The LacZ-treated wt mice were able to
ecognize a previously encountered female only after
n interexposure interval (IEI) of 0.5 hr (p < 0.001). After
EI of 2 hr, 6 hr, and 24 hr, the LacZ-treated wt mice
pent similar amounts of time investigating the same
nd novel females, indicating a lack of social discrimi-
ation. There was no difference in the time spent in the
nitial investigation of the same female between the
SE-V1aR and LacZ viral vector-treated animals for any
f the IEIs.
eceptor Autoradiography
1aR overexpression in the lateral septum of wt mice
as confirmed using V1aR autoradiography. The wt
ice treated with the NSE-V1aR viral vector in the lat-
ral septum had an average V1aR binding (dpm/mg) in
he lateral septum of 4631.28 ± 328.3 (Figure 7A), while
t mice treated with the LacZ control virus in the lateral
eptum had an average V1aR binding (dpm/mg) in the
ateral septum of 2036.78 ± 113.1 (Figure 7B). The over-
xpression of the V1aR using the NSE-V1aR viral vector
as statistically significant (p < 0.001) and resulted in
n almost 100% increase in V1aR binding in the lateral
eptum of wt mice; however, there was some spread
nto the surrounding regions including the medial
eptum.
iscussion
he results of this study definitively establish a role for
he lateral septum in V1aR-regulated social recognition
n male mice. Furthermore, these findings suggest that,
hile both the lateral septum and medial amygdala
ave been previously shown to be important regions
or social recognition, it is V1aR in the lateral septum
nd not in the medial amygdala that is critical to social
ecognition, and the social behavior effects of a null
utation in the V1aR gene can be reversed by V1aR
ctivation in the lateral septum alone. In addition, these
indings support our previous report on the profound
ocial recognition deficits in mice with a null mutation
n the V1aR gene. Given the results of this current study,
t appears that disruption of social recognition in the
1aRKO mice may have been due to the specific lack
f V1aR activation in the lateral septum.
While the hypothalamus is the major source of AVP
roduction, there is also an extrahypothalamic AVP
ystem, and this sexually dimorphic system plays a
ritical role in the central and behavioral effects of AVP
de Vries and Miller, 1998). AVP is synthesized in the
edial amygdala and the bed nucleus of the stria ter-
inalis, and these AVP neurons project to forebrain
tructures including but not limited to the lateral sep-
um. However, the lateral septum contains a dense
V1aR and Social Cognition
507Figure 6. Social Discrimination
Social discrimination of NSE-V1aR viral vector-treated (open circles; n = 12) and LacZ virus-treated (closed circles; n = 10) wt mice as measured
by the olfactory investigation times of a previously encountered female (same) and a novel female (novel) during a simultaneous exposure of
5 min, with varying interexposure intervals (IEI) of (A) 0.5 hr, (B) 2 hr, (C) 6 hr, and (D) 24 hr, after the initial 5 min exposure to the (same)
female. After an IEI of 0.5 hr, both groups spent more time investigating the novel female. After 2 hr, 6 hr, and 24 hr, only the NSE-V1aR viral
vector-treated wt males spent significantly more time investigating the novel females. Error bars represent SEM. *p < 0.001, **p < 0.01.plexus of AVP-containing fibers (de Vries and Miller,
1998). V1aR binding autoradiograms show very dark
and concentrated binding in the lateral septum, sug-
gesting that this area is rich in V1aR and may be an
important area in AVP-controlled behaviors (Barberis
and Tribollet, 1996; Bielsky et al., 2004). Furthermore,
the lateral septum projects to many hypothalamic re-
gions, including the medial preoptic area, that are in-
volved in the regulation of social behaviors, including
male sexual behaviors (Sheehan and Numan, 2000).
The lateral septum is also capable of receiving informa-
tion from the olfactory vomeronasal system, which
would be critical to the ability of an animal to use scent
for social recognition (Risold and Swanson, 1997). The
circuitry and neurochemistry of the lateral septum make
an attractive target for the study of social recognition
in male mice.
Social Recognition
The ability to recognize a familiar conspecific is the
foundation for all social relationships, including parent-offspring relationships, pair bonding in voles, domi-
nant-subordinate hierarchies in hamsters, social status
in fish, and courtship and aggression in birds, and while
these behavioral examples vary in both expression and
species, they all share the involvement of AVP or its
nonmammalian analog AVT (Ferris et al., 1986; Bam-
shad and Albers, 1996; Chu et al., 1998; Goodson and
Adkins-Regan, 1999; Parker and Lee, 2001; Semsar et
al., 2001; Lim and Young, 2004). The role for AVP in
social cognition appears to be heavily conserved
across species, as does the presence of AVP and the
V1aR in the lateral septum. While the importance of
species-typical binding and expression patterns of
V1aR and AVP have been demonstrated in some of the
above behaviors, including pair bonding in voles, the
existence of septal V1aR does not differ greatly and
thus may be responsible for the underlying social rec-
ognition that is the foundation for the complex social
behaviors.
Social recognition tasks were originally introduced as
nonaversive alternatives to the traditional avoidance tests
Neuron
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V1aR binding autoradiograms illustrating 125I
V1aR antagonist binding in LacZ virus-
treated wt (A) and V1aRKO (C) and NSE-
V1aR viral vector-treated wt (B) and V1aRKO
(D) at the level of the lateral septum injec-
tion site.for learning and memory (reviewed in van Wimersma s
AGreidanus et al., 1983). However, more recent investiga-
tions have demonstrated that social recognition is a b
unique form of learning and memory that utilizes dis-
tinct neural mechanisms that are specific to social cog- d
inition (van Wimersma Greidanus and Maigret, 1996). These
paradigms allow investigation of a critical component r
eof the social brain. Mice have been shown to demon-
strate distinct forms of social memory, one transient (
dand the other more enduring. The transient social mem-
ories, like those tested in the current studies, are normally o
wheld for up to an hour and seem geared more toward the
differentiation of conspecifics over short interactions or s
(durations and involve the ability to distinguish between
two similar but different olfactory signatures (reviewed i
tin Ferguson et al., 2002). More enduring, long-term so-
cial memories were not tested in these studies. i
gThere is considerable experimental evidence that the
lateral septum is involved in the control of social rec- d
oognition behaviors. Lesions of the lateral septum re-
sulted in altered social behavior, and AVP injections di- a
trectly into the lateral septum resulted in enhanced
social recognition in male rats (Clarke and File, 1982; d
uDantzer et al., 1988). Treatment with AVP antagonists
and V1aR-specific antagonists injected in the lateral t
tseptum have both been found to significantly disrupt
social recognition as well as treatment with anti-AVP m
iserum into the septal area (Dantzer et al., 1988; van
Wimersma Greidanus and Maigret, 1996; Everts and t
tKoolhaas, 1997, 1999). V1aR antisense oligos have also
been shown to disrupt normal social recognition and c
malter anxiety-related behavior in male rats when in-
jected into the lateral septum (Landgraf et al., 1995). In s
dcontrast, social recognition in female rats is indepen-
dent of vasopressin transmission, which is probably o
tdue, in part, to the sexual dimorphism of the extrahypo-
thalamic AVP system, which is markedly reduced in fe- o
gmales (Bluthe and Dantzer, 1990; de Vries and Miller,
1998). While the importance of the lateral septum in va-
osopressinergic social recognition has been well estab-
lished in rats, the lack of septal research in mice neces- n
ssitated the current studies. Furthermore, the lateraleptum is not the only extrahypothalamic region rich in
VP that has been shown to affect social recognition in
oth rats and mice.
Like the lateral septum, the BNST and medial amyg-
ala are regions rich in both AVP and V1aRs. The major-
ty of extrahypothalamic AVP is produced by the neu-
ons in the medial amygdala and BNST, a part of the
xtended amygdala, and project to the lateral septum
de Vries and Miller, 1998). Lesions of the medial amyg-
ala in neonatal rats resulted in impaired social rec-
gnition and social play; however, rhesus macaques
ith bilateral lesions of the medial amygdala demon-
trated normal social interactions with conspecifics
Daenen et al., 2002; Amaral et al., 2003). Investigations
nto the behavioral effects of a null mutation in the oxy-
ocin gene (OTKO) revealed that the medial amygdala
s critical to normal social recognition in male mice (Fer-
uson et al., 2001). Oxytocin is a nonapeptide also pro-
uced in the hypothalamus that differs from AVP by
nly two amino acids. OTKO male mice demonstrated
complete disruption of social recognition similar to
hat seen in V1aRKO mice (Ferguson et al., 2000). This
eficit also resulted in decreased neuronal activation,
sing c-fos as a marker, in the medial amygdala but not
he lateral septum. Social recognition was rescued in
hese mice after treatment of oxytocin directly into the
edial amygdala (Ferguson et al., 2001). AVP treatment
n the OTKO mice did not restore normal social recogni-
ion (Ferguson et al., 2000). These findings suggest that
he medial amygdala is involved in the regulation of so-
ial recognition but it was unclear whether AVP trans-
ission is required in this area. The current findings
uggest that V1aR activation is not required in the me-
ial amygdala and that V1aR expression is required
nly in the lateral septum for normal social recognition
o occur. The role of the BNST in vasopressin effects
n social recognition is still unclear and was not investi-
ated in the current studies.
A mechanism to increase the duration of social mem-
ry would be critical to establishing dominant-subordi-
ate relationships and pair bonding in monogamous
pecies, which are examples of long-term social mem-
V1aR and Social Cognition
509ories that have an emotionally salient aspect. It is pos-
sible that emotional or stressful situations could in-
crease the saliency of a social encounter and lead to a
potentiation of social recognition or conversion to a more
long-lasting social memory. The examples above and
the findings in hamsters, that males who lose a fight
form long-term social memories, lend support to this
hypothesis (Lai and Johnston, 2002). The current para-
digms used a largely innocuous exposure to a nonre-
ceptive female and thus may not be the most potent
initiator of social recognition. It is possible that in-
creased levels of AVP release and thus V1aR activation
may increase the duration of social memory. Not sur-
prisingly, stressful and sexual encounters have been
shown to cause increases AVP release, and thus such
significant encounters would result in a facilitation of
social memory needed to remember a mate or an ad-
versary/predator (Wotjak et al., 1996; J.C. Morales et
al., 2004, Soc. Neurosci., abstract; Wigger et al., 2004).
The prairie vole NSE-V1aR viral vector used in the
current mouse studies has been used successfully in
several other species. Ventral pallidum injections in
prairie and montane voles resulted in increased affilia-
tive behaviors in both species (Pitkow et al., 2001; Lim
et al., 2004). Septal injections of the same viral vector
in male rats resulted in a significant facilitation of social
discrimination similar to, but not as sustained as, that
seen in the current study (Landgraf et al., 2003). These
findings support the current studies, that V1aR expres-
sion in discrete brain regions is involved in social and
anxiety-like behaviors. The use of a viral vector to induce
sight-specific expression of a single gene is not without
problems, however. It is difficult to tightly control the
spread of the viral injection, and it is not unusual to get
expression in the adjacent brain regions. Furthermore,
the viral vector used in this study has a neuron-specific
promoter but not a V1aR neuron-specific promoter;
thus, it is probable that the V1aR is being expressed in
genes that would not normally express this gene; how-
ever, it is probably not expressed in glia. Even in light
of these shortcomings, the current NSE-V1aR viral vec-
tor has been used with great efficacy and provides an
important model for the study of the behavioral effects
of regional changes in gene expression.
Anxiety-Like Behaviors
Pharmacological evidence for the role of AVP and the
V1aR in anxiety-related behavior in rats has historically
been contradictory. One group has reported an anxio-
lytic effect of AVP administration and no effect of AVP
antagonists, while others have reported no effect of
AVP administration but an anxiolytic effect of V1aR an-
tagonist (Liebsch et al., 1996; Appenrodt et al., 1998).
Still another group reported an anxiogenic-like effect
after treatment with an AVP receptor antagonist (Everts
and Koolhaas, 1999). Treatment with an orally active
V1bR antagonist resulted in a decrease in anxiety-like
behavior in rats; however, a study of V1bRKO mice re-
ported no effect of the null mutation in anxiety-related
behavior (Griebel et al., 2002; Wersinger et al., 2002).
Furthermore, septal injection of a selective V1bR antag-
onist resulted in antidepressant, but not anxiolytic, be-
havior in rats (Stemmelin et al., 2005). Nonpharmaco-logical studies have shown that V1aR antisense oligos
injected into the lateral septum have an anxiolytic-like
effect on male rats, and our previous findings with the
V1aRKO showed a decrease in anxiety-like behavior in
the V1aRKO as compared to the wt (Landgraf et al.,
1995; Bielsky et al., 2004).
The current findings suggest that, while V1aR expres-
sion in the lateral septum may contribute to the normal
anxiety-like behavior, reexpressing V1aR in V1aRKO in
the lateral septum is not sufficient to alter such behav-
ior. While expression of V1aR in the V1aRKO mice did
not alter anxiety-like behaviors, increased expression
of V1aR in wt mice did result in increased anxiety-like
behaviors. The current anxiety-related behavior data
suggest that, while the V1aR is important for anxiety-
related behavior, it must rely on other developmental,
neurochemical, or neuroanatomical factors. The V1aRKO
mice developed with a total absence of V1aR expres-
sion and activation both in the periphery and centrally,
and thus it is not surprising that reexpression in a single
area did not affect anxiety-like behavior in these mice.
The increase in anxiety-related behavior in response to
overexpression of V1aR in the wts demonstrates that
the V1aR expression modulates anxiety-like behavior
but that gene replacement during adulthood is not suffi-
cient to overcome constitutive lack of V1aR, which could
be critical in other regions as well or be responsible for
downstream neuronal or chemical connections that are
not formed in the V1aRKO mice.
A correlation between performance on anxiety-related
tasks and hippocampal-dependent learning has been
established and thus must be addressed given the anx-
iety-like effects of V1aR re- and overexpression (Bel-
zung and Griebel, 2001; Bannerman et al., 2004; Pack-
ard and Wingard, 2004; Deacon and Rawlins, 2005).
The initial behavioral phenotyping of the V1aRKO mice
found no effect of the null mutation on hippocampal-
dependent learning as assessed by the Morris water
maze (MWM) and found that the non-hippocampal-
dependent impairment in social recognition was con-
current with a decrease in anxiety (Bielsky et al., 2004).
These findings cannot be accounted for by a correla-
tion between decreased anxiety-like behavior and im-
provement in hippocampal-dependent learning, as the
relationship in the V1aRKO mice was found to be the
opposite. Furthermore, the current findings demonstrate
a facilitation of social recognition in both the V1aRKO
and wt animals that received V1aR viral vector injection
but opposing effects on anxiety-like behavior. The V1aRKO
mice that received V1aR reexpression showed a trend
toward decreased anxiety (although this was not signif-
icant), while the wt mice that received V1aR overexpres-
sion showed an increase in anxiety. These opposing ef-
fects on anxiety-related measures taken in concert with
the effects on social memory and the previous MWM
findings therefore suggest that the relationship be-
tween hippocampal-dependent learning and anxiety is
not relevant here.
The current findings suggest that the lateral septum
may provide a convergence or relay point in the social
olfactory circuit by receiving olfactory information from
the conspecifics and delivering necessary information
to the hypothalamus, with its role in sexual behaviors,
and the hippocampus, with its role in learning and
Neuron
510wmemory, both of which are integral parts of behavioral
mresponses to social stimuli. AVP via activation of the
tV1aR may be the modulator required for normal cir-
i
cuitry functioning in the lateral septum, thus social cog- P
nition and aspects of anxiety-like behavior are depen- w
bdent on V1aR activation in the lateral septum of male
fmice. These findings do not rule out the possible impor-
2tance of V1bR and OTR in cognition and emotionality,
hbut the localizations of actions are still under investiga-
a
tion. Finally, the use of viral vector technology in con- h
cert with transgenic mice in the current studies pro- i
vides an innovative model for targeting the role of a h





dAll subjects were 2- to 5-month-old sexually naive male mice. The
tanimals were maintained in a 14/10 hr light/dark cycle and were
lprovided food and water ad libitum (Purina mouse chow; Purina
tMills, St. Louis, MO). Animals were housed in groups of three to
afive for the anxiety testing and then individually housed for the re-
cmainder of the experiments. All experiments were performed in
Ccompliance with the rules and oversight of the Emory Institutional
iAnimal Care and Use Committee.
d
mWt Mice
cSubjects were male C57/BL6 mice ordered from Jackson Labora-
ttory (Bar Harbor, ME). Four groups of wt male mice were used in
pthe antagonist studies: experimental groups receiving a V1aR an-
tagonist treatment into the lateral septum (n = 9) or the medial
amygdala (n = 8), and control groups receiving vehicle into the lat-
Veral septum (n = 8) or medial amygdala (n = 7). Two groups of wt
Vmale mice were used in the viral vector studies: an adeno-associ-
iated NSE-V1aR viral vector treatment group (NSE-V1aR) (n = 11) or
va control LacZ viral vector treatment group (LacZ) (n = 10).
t
sV1aRKO Mice
aSubjects were knockout mice (−/−) (V1aRKO) bred in our laboratory.
dBriefly, the mice were produced by standard homologous recombi-
enation in which neo gene replacement deleted a 1.5 kb fragment of
sthe V1aR gene starting at 31 bp downstream of the translation start
isite and ending at 244 bp downstream of exon #I. Chimeric males
swere generated and mated to C57/BL6 females, and germline trans-
hmission was achieved. These animals were backcrossed to 129/SvJ
tfor five generations, and experimental mice were produced from
oheterozygote crossings (Hu et al., 2003). The genotype of all ani-
smals was assessed using a PCR-based genotyping protocol as
qpreviously described (Bielsky et al., 2004). Two groups of V1aRKO
bmale mice were used in these studies: an adeno-associated NSE-
rV1aR viral vector treatment group (NSE-V1aR) (n = 15), and a con-
itrol LacZ viral vector treatment group (LacZ) (n = 8).
l
pAntagonist Injections
iOn the afternoon before behavior testing, animals were site specif-
sically injected bilaterally into either the lateral septum or the medial
tamygdala with either 5 ng of V1aR antagonist or vehicle (Ringer’s
tsolution). Antagonist dose was chosen based on previous findings
vusing site-specific antagonist injections (Lim and Young, 2004).
oAnimals were anesthetized with isoflurane anesthesia adminis-
Vtered using an anesthesia airflow machine (Vetequip, CA) and
mplaced into Kopf stereotaxic apparatus using blunt earbars to pre-
gvent eardrum puncture. Coordinates for the lateral septum and
Bmedial amygdala were determined by dye injections (lateral sep-
(tum: AP +0.6 mm, ML ±0.4 mm, DV −4.0 mm from dura; medial
aamygdala: AP −1.8 mm, ML ±2.6 mm, DV −5.4 mm from dura). The
ascalp was incised, and a dental drill was used to create a 1 mm3
ahole in the skull, whereupon a Hamilton syringe was lowered, and
t0.5 l of V1aR antagonist was injected. The V1aR antagonist
f[d(CH2)51,Tyr(Me)2,Arg8]-Vasopressin (Bachem, CA) was dissolved
in lactated Ringer’s solution (Fisher Scientific, Pittsburgh, PA) and was previously shown to be selective and behaviorally effective in
ice (Boccia et al., 1998). Bilateral control injections were given in
he same manner using 0.5 l of lactated Ringer’s solution. Bilateral
njections were given using an automatic micropump (World
recision Instruments, FL) at a rate of 1 nl/s. After surgery, animals
ere removed from the anesthesia setup and generally awakened
etween 2 and 7 min after the surgery. Behavioral testing was per-
ormed the morning after surgery in an isolated behavior room at
3°C–24°C. The V1aR antagonist has been shown previously to
ave a receptor occupancy window in vivo of 18–24 hr (Winslow et
l., 1993). Animals were brought to the testing room at 07:00, an
our before testing began, to acclimate to the environment. Behav-
or testing occurred at 08:00, 16 hr after surgery, during the first
alf of the light part of the light/dark cycle. Immediately after test-
ng, animals were sacrificed, and the brains were removed, flash
rozen, sectioned at 20 m, and slide mounted. A visual inspection
f slices was used to confirm correct injection placement. A total
f nine animals, four antagonist (one in the lateral septum, three in
he medial amygdala) and five controls, were excluded from the
ata analysis because of illness due to surgery or improper injec-
ion placement. Correct lateral septum injection was defined by
ocation of the injection tip within the lateral septal complex, medial
o the lateral ventricles, ventral to the dorsal peduncular cortex,
nd lateral to the medial septum. The lateral septal complex in-
ludes the dorsal (LSD), intermediate (LSI), and ventral (LSV) parts.
orrect medial amygdala injection was defined by location of the
njection tip within the medial amygdala complex, ventral and me-
ial to the central amygdala and basolateral amygdala nuclei. The
edial amygdala complex includes the basomedial amygdala nu-
leus, the posterodorsal medial amygdala nucleus, and the pos-
eroventral medial amygdala nucleus. Any injections outside these
arameters were excluded.
iral Vector Injections
1aRKO and wt animals were site specifically injected bilaterally
nto the lateral septum with either adeno-associated V1aR viral
ector (NSE-V1aR) or control LacZ viral vector. Animals were anes-
hetized with isoflurane anesthesia administered using an anesthe-
ia airflow machine (Vetequip, CA) and placed into Kopf stereotaxic
pparatus using blunt earbars to prevent eardrum puncture. Coor-
inates for the lateral septum were determined by dye injections (lat-
ral septum: AP +0.6 mm, ML ±0.4 mm, DV −4.0 mm from dura). The
calp was incised, and a dental drill was used to create a 1 mm3 hole
n the skull, whereupon a Hamilton syringe was lowered, and 0.5 l/
ide of NSE-V1aR was injected. The production of the NSE-V1aR
as been previously described in detail (Pitkow et al., 2001). Briefly,
he neuron-specific enolase (NSE) prairie vole NSE-V1aR consists
f a V1aR genomic clone with the majority of the intron removed,
pliced downstream of a rat NSE promoter. The V1aR modified se-
uence contains the first and second exons separated by a 287
p intron and a 227 bp 5#-untranslated region. The NSE promoter
estricts expression to neurons, and transduction by AAV-2 vectors
nto the brain is usually confined to neurons (Peel et al., 1997; Bart-
ett et al., 1998; Nair and Young, 2002). The LacZ virus was pre-
ared very similarly, by incorporating a 0.6kb cytomegalovirus-
mmediate early promoter and the 3.7kb Escherichia coli lacZ gene
equence. The packaging of AAV plasmids was performed using
he standard methods previously described. AAV vector stock was
itrated using real-time PCR and averaged 1 × 1011/ml. The viral
ector was completely free of the contaminating helper virus and
nly contained the gene of interest with no viral genes. The NSE-
1aR was dissolved in lactated Ringer’s solution so that each ani-
al received a total of 0.5 l/side. Bilateral control injections were
iven in the same manner using 0.5 l/side of LacZ viral vector.
ilateral injections were given using an automatic micropump
World Precision Instruments, FL) at a rate of 1 nl/s. After surgery,
nimals were removed from the anesthesia setup and generally
wakened between 2 and 7 min after the surgery. Animals were
llowed to recover for at least 7 days before beginning behavioral
esting. A total of four animals, all wt V1aR treated, were removed
rom analysis due to illness or improper injection placement, which
as defined as described above for the lateral septum.
V1aR and Social Cognition
511Behavioral Testing
All testing was performed in an isolated behavior room at 23°C–
24°C. Animals were brought to the testing room an hour before
testing began, to acclimate to the environment. All behavior testing
occurred in the first half of the light part of the light/dark cycle. All
behaviors were videotaped and scored later by a single trained
observer blind to genotype using a computer-assisted data acquisi-
tion system (Stopwatch+; http://www.cbn-atl.org/organization/
stopwatch.html). For all anxiety tests, the light in the room mea-
sured 300–400 lux. Each behavioral test was separated by at least
24 hr, and tests were performed in the order presented. Animals
were group housed during anxiety testing and individually housed
for olfactory and social testing. Anxiety tests took place on sepa-
rate days and preceded olfactory and social testing where applic-
able.
Elevated Plus Maze
The elevated plus maze apparatus consisted of two open arms and
two closed arms, each measuring 30.5 × 7.6 cm and elevated 81
cm above the ground. The subject was placed in the center of the
apparatus facing the open arm, and its location was recorded for
5 min. An arm entry was defined as the mouse having all four paws
into the arm (Fernandes and File, 1996). The number of dark arm
entries was also recorded in order to assess general locomotion
behavior.
Open Field
The open field apparatus consisted of a clear-walled, Plexiglas,
rectangular open arena with a length of 45.5 cm and a width of 40.5
cm. This arena is attached to an automated photo-beam activity
system that tracks movement by recording photo-beam breaks
(San Diego Instruments, Flex Field Photo-beam system) The sub-
ject was placed in the arena, along the wall, and its location was
recorded for 5 min. The photo-beam system records the number of
beam breaks and where the beam breaks occur. This measure di-
rectly correlates to the distance traveled, which is a measure of
general locomotor activity. The critical anxiety-like behavior mea-
sure was the time spent in the inner area of the arena (>5 cm away
from any wall), which was scored by hand.
Light/Dark Box
The light/dark box apparatus consisted of a light, open-topped,
opaque, Plexiglas box connected to a dark, closed-topped,
opaque, Plexiglas box, each measuring 27.5 × 17.5 × 12.5 cm. The
boxes were connected by a small opening that allowed the subject
to cross between them. The subject was placed in the light box,
and its location was recorded for 5 min. The time spent in the light
side of apparatus was considered the primary measure of the anxi-
ety because of its sensitivity to anxiolytics (Hascoët et al., 2001).
Light box entry was defined as the mouse having all four paws into
the light box.
Olfactory Habituation
Animals were individually housed for at least 10 days before test-
ing, and olfactory habituation was performed 7 days after social
recognition. The procedure was used previously by Ferguson et al.
(2000). Briefly, a small plastic cartridge was packed with cotton
scented with 10 l of anise extract. This was placed in the home
cage of the subject for 1 min over four trials, with an intertrial in-
terval (ITI) of 10 min. In the fifth dishabituation trial, the subject was
presented with a cotton ball scented with 10 l of coconut extract.
The time spent in olfactory investigation for each trial was re-
corded. Olfactory investigation was defined as direct nasal contact
with the cartridge.
Social Recognition
Animals were individually housed for 10 days before testing to per-
mit the establishment of a home cage territory. The procedure was
the same as previously used in Ferguson et al. (2000). Briefly, the
subject was exposed to the same ovariectomized adult female
mouse for 1 min over four trials with an ITI of 10 min. During the
fifth dishabituation trial, the subject was exposed to a novel ovari-
ectomized female for 1 min. The time spent in olfactory investiga-
tion for each trial was recorded. Olfactory investigation was defined
as direct, active, olfactory exploration of the stimulus female, spe-
cifically nosing and sniffing of the head and anogenital regions,
closely following, and pursuit. Each female was used only once
each day. Mice displaying normal social recognition show a decline
in investigation upon subsequent exposure to the same individual,and in the dishabituation trial, investigation times are similar to the
initial exposure to the first individual.
Social Discrimination
The animals were individually house for 10 days before testing to
allow the establishment of a home territory. The social discrimina-
tion paradigm has been described previously (Ferguson et al.,
2002; Bielsky and Young, 2004). Briefly, the test animal is exposed
to the stimulus ovariectomized female animal and then, after an ITI,
simultaneously presented with the same stimulus female and a
novel stimulus ovariectomized female. Normally, the test animal will
spend significantly more time investigating the novel stimulus fe-
male as compared to the original stimulus female. Four different
ITIs were used: 0.5 hr, 2 hr, 6 hr, and 24 hr. This allowed for the
testing of possible social discrimination facilitation.
Data and Statistical Analysis
For the plus maze, open field, and light/dark box, the time spent in
the open arm, open field, and light box was compared between
treatment groups using a Student’s t test. The number of closed
arm entries in the plus maze and the distance traveled in the open
field were compared between treatment groups using a Student’s
t test. For the social recognition and olfactory habituation tests,
two-way ANOVAs, with treatment group and trial as factors, with
repeated measures on trial were performed. For the social discrimi-
nation test, a two-way ANOVA with stimulus type (novel female ver-
sus same female) and treatment as factors with repeated measures
on stimulus type was performed for each ITI time point. If a signifi-
cant main or interaction effect was detected, a Neuman-Keuls post
hoc analysis was performed (GraphPad Prism 4). The initial time
spent investigating the female was compared between treatment
types for each ITI using a Student’s t test (α = 0.05).
Receptor Autoradiography
To confirm V1aR viral vector expression and injection placement,
radioligand receptor binding was performed. Immediately after
completion of behavior testing, animals were sacrificed, and the
brains were removed and flash frozen on dry ice, sectioned at 20
m, and slide mounted into two serial sets for each experimental
animal. One set was used for V1aR binding, and the other was
archived. Sections were processed for receptor autoradiography
using 125I-labeled (Phenylacetyl1,0-Me-D-Tyr2, [125I-Arg6]-) vaso-
pressin (linear), V-1A antagonist (Perkin Elmer Life Analytical Sci-
ences, Boston, MA) for the V1aR as described previously (Young et
al., 1997). Slides were exposed to BioMax MR film (Kodak) for 48 hr.
A visual inspection of the V1aR autoradiogram was used to confirm
correct injection placement.
Data and Statistical Analysis
Film autoradiograms were analyzed using the AIS program (Im-
aging Research Inc., St. Catharines, ON, Canada). Optical densities
were converted to dpm/mg of tissue equivalents using 125I micro-
scales (Amersham, Arlington Heights, IL). Specific binding in the
lateral septum was obtained by subtracting the nonspecific binding
from the total binding for each section. All sections were analyzed
by a trained experimenter blind to treatment, and each region of
interest was measured bilaterally from at least two sections. Values
from V1aR- and LacZ-treated wt subjects were compared using
Student’s t test (α = 0.05).
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